Aarey Drugs & Pharmaceuticals Board of Directors

Get the latest insights into the leadership at Aarey Drugs & Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Mihir R Ghatalia Chairman & Managing Director
Mr. Nimit Rajesh Ghatalia Executive Director
Ms. Bina Rajesh Ghatalia Woman Director
Mr. Lalit Radhakrishna Tulsiani Independent Director
Mr. Anil Mandal Independent Director
Mr. Chetan K Mehta Independent Director

Aarey Drugs & Pharmaceuticals Share price

AAREYDRUGS

68.5

1.12 (-1.61%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

71.00

Today's Low

67.70

52 Week Low

31.35

52 Week High

74.80

The current prices are delayed, login to your account for live prices

Aarey Drugs & Pharmaceuticals FAQs

The board at Aarey Drugs & Pharmaceuticals consists of experienced professionals, including Mr. Mihir R Ghatalia , Mr. Nimit Rajesh Ghatalia , and others, overseeing the company’s strategic and corporate governance.

Directors at Aarey Drugs & Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Mihir R Ghatalia is the current chairman at Aarey Drugs & Pharmaceuticals.

Executive directors at Aarey Drugs & Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aarey Drugs & Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aarey Drugs & Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.